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Baeyer-Villiger monooxygenases catalyze the oxidation of
carbonylic substrates to ester or lactone products usingNADPH
as electron donor and molecular oxygen as oxidative reactant.
Using protein engineering, kinetics, microspectrophotometry,
crystallography, and intermediate analogs, we have captured
several snapshots along the catalytic cycle which highlight key
features in enzyme catalysis. After acting as electron donor, the
enzyme-bound NADP(H) forms an H-bond with the flavin
cofactor. This interaction is critical for stabilizing the oxygen-
activating flavin-peroxide intermediate that results from the
reaction of the reduced cofactor with oxygen. An essential
active-site arginine acts as anchoring element for proper bind-
ing of the ketone substrate. Its positively charged guanidinium
group can enhance the propensity of the substrate to undergo a
nucleophilic attack by the flavin-peroxide intermediate. Fur-
thermore, the arginine side chain, together with the NADP
ribose group, forms the niche that hosts the negatively charged
Criegee intermediate that is generated upon reaction of the
substrate with the flavin-peroxide. The fascinating ability of
Baeyer-Villiger monooxygenases to catalyze a complex multi-
step catalytic reaction originates from concerted action of this
Arg-NADP(H) pair and the flavin subsequently to promote fla-
vin reduction, oxygen activation, tetrahedral intermediate for-
mation, and product synthesis and release. The emerging pic-
ture is that these enzymes are mainly oxygen-activating and
“Criegee-stabilizing” catalysts that act on any chemically suita-
ble substrate that can diffuse into the active site, emphasizing
their potential value as toolboxes for biocatalytic applications.
Flavoprotein monooxygenases catalyze the insertion of an
oxygen atom into an organic substrate in hydroxylations,
epoxidations, Baeyer-Villiger oxidations, and N- and S-oxida-
tions (1–3). These enzymes activate molecular oxygen to over-
come its spin-forbidden reaction with an organic molecule
through formation of a stable C4a-(hydro)peroxy-flavin adduct
(the “flavin-peroxide,” Scheme 1) (4). In the case of Baeyer-
Villiger monooxygenases (BVMOs),3 the flavin-peroxide
nucleophilically attacks the carbonyl group of ketone substrates
with the formation of a covalent tetrahedral Criegee interme-
diate, analogous to the intermediate that forms in nonenzy-
matic Baeyer-Villiger oxidations (5). An electronic rearrange-
ment yields an ester or lactone, a water molecule, and the
oxidized flavin. A key feature of BVMOs and related monooxy-
genases is the dual role of NADP(H) in catalysis; it acts as the
electron donor to reduce the flavin, and it is required for the
stabilization of the essential flavin-peroxide intermediate
(6–10).
BVMOs are promising targets for biocatalytic applications
in synthetic and pharmaceutical chemistry (11, 12). Phenyl-
acetone monooxygenase (PAMO, EC 1.14.13.92) from Ther-
mobifida fusca features several attractive properties: it is
thermostable, tolerant to organic solvents (13, 14), and cat-
alyzes enantioselective Baeyer-Villiger oxidations and sul-
foxidations on a number of substrates in addition to phenyl-
acetone (15). The three-dimensional structure of PAMO has
been solved revealing a two-domain organization (Fig. 1A)
(16), and its catalytic cycle has been subject of extensive
kinetic studies (17–22). More recently, the structure of cyc-
lohexanone monooxygenase in complex with NADP high-
lighted a proposed mechanism for the dual catalytic role of
NADP(H) (9, 23).
Here, we present a biochemical, microspectrophotometric,
and structural investigation of PAMO which aims at the iden-
tification of the structural andmechanistic features that under-
lie the complex mechanism of function of BVMOs. The study
elucidates key aspects of oxygen activation and substrate oxy-
genation through the formation of the Criegee intermediate.
EXPERIMENTAL PROCEDURES
Proteins have been purified following published protocols
with few modifications (Table 1) (17, 24). Kinetic studies on
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D66A and R217A mutants were performed as described (17).
Wild-type, D66A, and R337K proteins were crystallized by
vapor diffusion at 4 °C using 1–3 l of protein solutions (18
mg/ml in 0.5 M FAD and 4 mM NADP, 50 mM Tris/HCl, pH
7.5) mixed with equal volumes of reservoir containing 40%
(w/v) PEG4000, 100 mM MES/HCl, pH 6.5, and 100 mM NaCl.
TheM446Gmutant could be crystallized only in the conditions
previously used for the ligand-free enzyme (16). All crystal
soaking experiments were performed at room temperature in
stabilizing solutions containing 4 mM NADP, 40% (w/v)
PEG4000, 100 mM MES/HCl, pH 6.5, and 150 mM NaCl. X-ray
diffraction data (Table 1) were collected at 100 K at ESRF
(Grenoble, France) and SLS (Villigen, Switzerland) and pro-
cessed with the CCP4 package (25). The structures were solved
and refined using the software PHASER (26), COOT (27), and
Refmac5 (28). Three-dimensional structure validation with the
program Molprobity (29) indicates that all models fall within
the 75th–95th percentiles of theMolprobity score. Supplemen-
tal Fig. S1 shows the Ramachadran plot of structure of the
R337Kmutant bound toMES. Single-crystalmicrospectropho-
tometric absorbance spectra were measured on cryo-cooled
crystals in both off-line (30) and on-line (31)modes at theCryo-
bench laboratory and at beam-line ID14-eh1 of ESRF, respec-
tively. Pictures were prepared with PyMOL (40) and CCP4mg
(32).
RESULTS
PAMO in Complex with NADP—The main goal of our
study was to advance our understanding of the enzymology
and structural chemistry underlying the function of Baeyer-
Villiger flavoenzymes using PAMO as model protein for the
enzyme class. Given the essential role of NADP in catalysis
(Scheme 1), a prerequisite toward this aim was to obtain well
diffracting crystals of the enzyme bound to the dinucleotide
ligand. The crystallization conditions used to solve the pre-
viously reported ligand-free enzyme structure contained
large amounts of ammonium sulfate which, as often reported
for dinucleotide-binding proteins, prevent NADP binding.
Optimization of the purification protocol and extensive
screenings led us to identify crystallization conditions using
PEG as precipitant with protein solutions containing an
excess of NADP. These well diffracting crystals (Table 1)
allowed us to solve the structure of the PAMO-NADP com-
plex by molecular replacement using the ligand-free struc-
SCHEME 1. Schematic representation of the Bayer-Villiger reaction catalyzed by PAMO.
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ture as search model (Fig. 1) (16). The overall conformations
of the individual NADP- and FAD-binding domains are very
similar in the ligand-free and NADP-bound structures as
indicated by root mean square deviations of 0.37 and 1.35 Å
for the C atoms, respectively (Fig. 1A; excluding residues
495–515). The only significant alterations are a 6° rotation of
the NADP-binding domain and a drastic conformational
change in the loop 495–515 of the FAD-binding domain.
This loop forms an elongated -hairpin in the ligand-free
enzyme whereas in the NADP complex it undergoes a large
(up to 6 Å) shift enabling extensive interactions with the
ADP-ribose moiety of NADP. The same change in loop
conformation has been described for cyclohexanone
monooxygenase, indicating that these structural alterations are
not crystallization artifacts (23). As a consequence of these con-
formational changes, the cleft at the domain interface becomes
narrower, being mostly occupied by the dinucleotide ligand
with the nicotinamide ring in direct contact with the dimethyl-
benzene moiety of the flavin (Fig. 2). In this way, NADP
together with the surrounding protein residues define the
boundaries of the substrate-binding site, which has the shape of
a funnel that extends from the protein surface to the flavin (Fig.
1C).
The Crystalline Enzyme Is Redox-reactive—We probed
PAMO-NADP crystals by microspectrophotometry (30, 31).
They exhibited a UV-visible absorbance spectrum very similar
to that measured from protein solutions (Fig. 3). Soaking the
crystals in NADPH-containing solutions did not cause any
bleaching of the flavin, implying that the crystal packing pre-
vents NADP displacement by NADPH (Fig. 1A). However,
soaking in dithionite-containing solutions led to flavin reduc-
tion, which takes place in 1–6min depending on the crystal size
(Fig. 3). The possibility ofmeasuring spectra during data collec-
tion allowed us to observe that x-ray irradiation induces rapid
crystal reduction, which is completed in relatively short times
(5–30 s; Fig. 3 inset) (31). Dithionite-reduced and x-ray-
induced crystals exhibit indistinguishable spectra and can be
reoxidized in 3–6 min by simple exposure to aerated solutions
(Fig. 3). These data demonstrate that the crystalline enzyme is
redox-reactive.
A point of concern in the crystallographic analysis was
whether the structure of the enzyme obtained by collecting
x-ray diffraction data on an oxidized crystal would represent
the actual conformation of the oxidized enzyme or whether
flavin photoreduction triggered by x-ray exposure (Fig. 3 inset)
resulted in the structure of the reduced enzyme. Diffraction
data are measured at 100 K, which is likely to prevent the con-
formational changes occurring during reduction (33) (see Fig.
2). In this scenario, the flavin is reduced by x-ray exposure, but
the surrounding protein environment does not relax to the
actual reduced protein conformation because of the cryo-
cooled state of the crystal (33). Several lines of evidence support
FIGURE 1. Crystallographic studies on PAMO. A, three-dimensional structure of PAMO in complex with NADP at 2.2-Å resolution. The NADP- and FAD-
binding domains are in light gray and gray, respectively. FAD is in yellow, NADP in orange. UponNADP binding, there is rearrangement of the loop 495–515;
the loop conformation of the unligated enzyme (Protein Data Bank ID code 1W4X) is in cyan, and that of the NADP-bound protein is in orange. B, final
weighted 2Fo Fc electron density map for the MES and NADP
 ligands at 1.5  level. Oxygens are in red, nitrogens in blue, phosphorus atoms inmagenta,
sulfurs in yellow, ligand carbons in cyan, and flavin carbons in yellow. C, surface representation of the active-site region. The flavin is yellow, NADP is orange,
Arg-337 carbons are gray, Arg-337 nitrogens are blue.
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this interpretation. (i) PAMO crystals are remarkably robust in
that they can be subjected to repeated cycles of reduction and
reoxidation without any substantial loss of the diffraction
power. This property allowed us to perform the following
experiment. A crystal was initially used for x-ray data collection
at 100 K. The crystal was then thawed and soaked in a dithion-
ite-containing reducing solution for 5–10 min. Next, it was
cryo-cooled and used for x-ray data collection. After this sec-
ond data collection experiment, the crystal was again thawed
and soaked in an aerated stabilizing solution to induce crystal
reoxidation. This allowed us to measure diffraction data from
the same crystal in the oxidized, reduced, and reoxidized state.
We could clearly observe that “initially oxidized” (i.e. crystals
that were not subject to any treatment before data collection)
and reoxidized proteins have the same conformationwhich dif-
fers from that of the reduced enzyme (Fig. 2, B and C). (ii) The
same conformational changes observed upon dithionite reduc-
tion were observed by photoreducing the crystals. This feature
could be observed by performing the following experiment.
Crystals were cryo-cooled at 100 K, exposed to x-rays to induce
photoreduction, thawed from 100 K to room temperature by a
brief (few seconds) soaking in a stabilizing solution, and finally
cryo-cooled again. Such a brief “room temperature” annealing
of an x-ray reduced crystal is too short to allow reoxidation, but
it is long enough to allow the crystalline protein to relax to the
reduced-state conformation which, indeed, turns out to be
identical to that of exhibited by dithionite-reduced crystals (Fig.
2) (34–36). (iii) We used different data collection strategies to
probe the effect of x-ray irradiation. In one experiment, we
generated a composite data set by merging diffraction
frames measured on several crystals at the beginning of data
collection (i.e. when the crystalline proteins are still mostly
oxidized). In another experiment, we used the helical data
collection strategy (35) that continuously exposes fresh
(nonirradiated) crystal regions. For both data collection
strategies, the resulting electron densities were identical to
those obtained from standard data sets measured on single
initially oxidized crystals.
These findings indicate that the atomicmodel obtained from
data measured on initially oxidized crystals visualizes the con-
formation of the oxidized-state protein. Likewise, the structure
obtained fromdithionite-reduced crystals is taken as amodel of
the enzyme in the reduced-state conformation.
Reduced Enzyme Structure—Enzyme reduction by dithionite
does not cause overall conformational changes as indicated by
the root mean square deviation from the oxidized enzyme C
positions of 0.3 Å (Fig. 2, A and B). Inspection of the active site
shows two localized but functionally highly relevant structural
alterations. In the oxidized enzyme, Arg-337 is engaged in
H-bonds with the NADP carboxamide group and the side
chain of Asp-66 (Fig. 2A). Upon enzyme reduction, Arg-337
moves away from NADP pointing toward the pyrimidine
moiety of the flavin ring. In this way, an electrostatically
favored interaction between the positively charged guani-
dinium group of Arg-337 and the negatively charged reduced
flavin can be established (Fig. 2B). At the same time, the
carboxamide group of the nicotinamide ring slightly rotates
toward the flavin to form an H-bond with the N5 atom of the
reduced cofactor. The key point emerging from the reduced
enzyme structure is that formation of the negatively charged
reduced cofactor is associated with a localized rearrange-
ment of the two central elements of the catalytic site;
NADP and Arg-337 (Scheme 1).
The Complex with MES Reveals an Oxyanion Hole—In the
course of the crystallographic studies, we often observed a
strong electron density peak, which was particularly evident in
crystals soaked in solutions containing increased MES buffer
TABLE 1
Crystallographic data collection and refinement statistics
Protein purification: plasmids were transformed into Escherichia coli TOP10 cells (Invitrogen), and the resulting colonies were preinoculated into LB broth supplemented
with 100g/ml ampicillin and grownovernight at 37 °C. Cultureswere then inoculated (startingA600 0.1) and grown in 2-liter Erlenmeyer flasks at 30 °C in 800ml of Terrific
Broth medium supplemented with 100g/ml ampicillin and 0.02% (w/v) L-()-arabinose for 20 h. E. coli cells were harvested by centrifugation at room temperature. Cells
were resuspended in 50mMTris/HCl, pH 7.5, at 25 °C and 10M FAD (5ml of buffer/g of cells). The crude extract obtained by sonication was incubated at 50 °C for 30min
and centrifugated at 70,000 g. Proteins were loaded onto a HiLoad 16/10 Q-Sepharose column (GEHealthcare) preequilibrated in 50mMTris/HCl, pH 7.5, at 25 °C. The















bound to MES M446G
PDBa code 2YLR 2YLS 2YLT 2YM1 2YM2 2YLW 2YLX 2YLZ
Beam line ID14eh1 ID14eh1 ID14eh1 ID14eh2 ID14eh1 PXI ID14eh1 ID23eh2














a 86.8 b 115.9
c 166.6
Space group P3221 P3221 P3221 P3221 P3221 P3221 P3221 I222
Resolution (Å) 2.26 2.26 2.65 2.28 2.7 2.9 2.2 2.0
Rsymb,c (%) 8.4 (26.9) 9.0 (30.4) 10.8 (51.6) 9.6 (49.8) 11.4 (46.3) 5.2 (8.4) 8.5 (44.8) 8.8 (41.8)
Completenessc (%) 99.9 (99.6) 99.6 (98.8) 99.3 (99.8) 99.8 (100) 99.8 (99.6) 98 (97.0) 100 (100) 100 (100)
Unique reflections 34,179 34,153 21,047 33,327 20,544 15,840 36,752 56,991
Redundancyc 4.2 (4.0) 3.0 (2.9) 3.6 (3.7) 4.7 (4.7) 4.2 (4.4) 4.6 (4.1) 4.3 (4.3) 4.0 (4.0)
I/b 12.6 (4.7) 8.7 (3.4) 9.9 (2.6) 11.6 (3.0) 9.5 (3.3) 20.8 (12.9) 11.8 (3.1) 11.6 (4.8)
No. of atoms 4,620 4,569 4,461 4,496 4,378 4,392 4,698 4,657
Average B value (Å2) 25.2 23.5 34.0 29.9 35.5 11.9 34.4 26.2
Rcrystd (%) 18.9 18.9 19.6 20.0 20.0 18.4 19.5 19.2
Rfree d (%) 23.8 23.5 26.1 24.5 25.9 26.6 25.2 22.6
Rmse bond length (Å) 0.019 0.022 0.016 0.018 0.016 0.022 0.021 0.019
Rms bond angles (°) 1.8 1.9 1.7 1.7 1.7 2.0 1.9 1.6
a PDB, Protein Data Bank.
bRsym Ii I/Ii, where Ii is the intensity of ith observation and I is the mean intensity of the reflection.
c Values in parentheses are for reflections in the highest resolution shell.
d Rcryst Fobs Fcalc/Fobs where Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively. Rcryst and Rfree were calculated using the work-
ing and test set, respectively.
e Rms, root mean square.
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concentrations.4 Motivated by this observation, we performed
soaking experiments in highly concentrated (400 mM) MES
solutions. The resulting electron densities clearly indicated that
a MES molecule binds in the active site in direct contact with
Arg-337 and the ribose group of NADP (Fig. 1B). Such a bind-
ing mode positions the ligand morpholino ring in the funnel
leading to the flavin cofactor (Fig. 4A).We also found thatMES
is a competitive inhibitor of PAMO although with low affinity
(Ki in the millimolar range).4 The electron density obtained
from dithionite-reduced crystals soaked in MES solutions did
not indicate the presence of any ligandmolecule, whose binding
is evidently impeded by the negatively charged reduced flavin.
The finding that MES specifically binds to the active site of the
oxidized protein is particularly insightful in that the ligand sul-
fonic group is H-bonded to the side chain of Arg-337 and the
2-hydroxyl group of the NADP ribose (Fig. 4A and Scheme
1). This observation suggests that one of the elements of the
catalytic armamentarium of BVMOs is the presence of a sort of
oxyanion hole in the catalytic center, formed by the Arg-337-
NADP pair.
R337K and Active-site H-bond Network—Mutagenesis stud-
ies have shown that Arg-337 is essential for catalysis in a
remarkable way (17). The Arg-337 mutants are reduced by
NADPHand form an extremely stable flavin-peroxide interme-
diate (Scheme 1). Their lack of catalytic activity results from
impaired ability to oxygenate the organic substrate. Given these
functional features, we performed the structural elucidation of
the R337K mutant in both oxidized and reduced states. The
mutation causes virtually no conformational changes with
respect to the wild-type structures (Fig. 2C). In the oxidized
state, Lys-337 amino group interacts with the carboxamide of
the NADP and the side chain of Asp-66. Upon reduction,
Lys-337moves toward the flavin, adopting a conformation sim-
ilar to that of Arg-337 in the reduced wild-type protein. Fur-
thermore, R337K retains the ability to bind MES which, how-
ever, can form anH-bond only with theNADP ribose because
of the absence of the guanidinium group from the side chain in
position 337 (Fig. 4B). Different fromArg, the Lys amino group
is unable to simultaneously engage NADP, Asp-66, and
active-site ligand inH-bonding interactions (Fig. 4,A andB). As
a result, the fine geometry of the oxyanion hole formed by Arg-
337 andNADP ribose is significantly affected, which prohibits
oxygenations to occur.
D66A Mutant and Substrate Entry—Having found that the
essential Arg-337 interacts with Asp-66 (in the oxidized pro-
tein; Fig. 2A), we studied the D66A mutant to probe the role of
this side chain in catalysis. Themutant protein is enzymatically
active with the oxidative step (the reaction with oxygen;
4 We repeatedly attempted crystal soaking in phenylacetone or similar sub-
strateswithout detecting clear binding in the crystals based on the inspec-
tion of the electron densitymaps. Because of the low affinity, it was impos-
sible to obtain an accurate measurement of the Ki for MES.
FIGURE2.Structural changesupon reductionbydithionite.A, active site of PAMO in complexwithNADP in theoxidized state. CarbonatomsofNADP are
cyan, flavin in yellow, protein residues in gray. Nitrogens are in blue, oxygens in red, sulfurs in yellow, and phosphorus atoms inmagenta. B, active-site structure
of the dithionite-reduced enzyme (2.2 Å). The nicotinamide and Arg-337 of the oxidized enzyme are superimposed and shown as thin lines. We tentatively
oriented the carboxamide group with the oxygen atom pointing toward the flavin, but it cannot be ruled out the carboxamide has the opposite orientation
with theNH2groupdirected toward the flavin.C, superimpositionof theoxidized and reduced states ofwild-type andR337K structures showing the same type
of shift by the side chain at position 337 upon reduction. Carbons of the oxidized proteins are in graywhereas those of the reduced proteins are in green.
Catalytic Mechanism of BVMOs
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Scheme 1) being unaffected by the mutation as indicated by a
second-order rate constant of 720 mM1 s1 (850 mM1 s1 in
the wild type) (17). The only step that is perturbed by themuta-
tion is the oxidation of NADPH which occurs with a rate con-
stant (0.5 s1) that is 24-fold lower than that of the wild-type
enzyme, making this step rate-limiting for the overall reaction.
Thus, Asp-66 plays a main (but not essential) role for proper
NADPHbinding and/or oxidation possibly because its negative
charge may help in the proper positioning of NADPH within
the active site (Scheme 1) and/or because it favors formation of
the positively charged oxidized NADP. The crystal structure
of the oxidized D66A shows that themutation leads to a shift in
the Arg-337 position. This side chain cannot bind to the side
chain in position 66 and adopts an extended conformation,
similar to that observed in the reduced wild-type protein (Fig.
4C). Remarkably, the electron density indicates that a MES
molecule is bound in the active site but in a position different
from that observed in thewild-type. This ligand is located at the
entrance of the funnel, and its sulfonic group is anchored to the
guanidinium of the extended Arg-337. It is tempting to specu-
late that this MES-binding mode represents a position tran-
siently adopted by the substrate during admission into the cat-
alytic site (see “Discussion”).
Reshaping the Substrate Binding Site—Met-446 is located at
the bottom of the substrate site (in the orientation of Figs. 2A
and 3A) (24). This residue is located in a loop (the so-called
“bulge”) that is critical for the enzyme substrate specificity (21).
The structure of the enzyme in complex with MES (Fig. 4A)
shows that the Met side chain interacts extensively with the
ligand on one side of the binding site. The M446G mutant
shows profoundly altered properties enabling the enzyme to act
on several aromatic compounds that are not substrates of the
wild-type protein (e.g. indigo) (24).We were only able to obtain
crystal of M446G in the ligand-free form (no NADP bound).
The structure shows no detectable conformational changes
with respect to the wild-type enzyme crystallized under the
same conditions. The only effect is that the removal ofMet-446
side chain widens the active site, whose shape is substantially
altered by the mutation.
DISCUSSION
The binding ofNADP to PAMO is virtually the same as that
observed in the structures of cyclohexanone monooxygenase
(23) and flavin-containing monooxygenases (6, 7), which all
share the property of utilizing NADP to stabilize the crucial
flavin-(hydro)peroxide. The data on cyclohexanone monooxy-
genase suggested a “sliding” process during catalysis. NADPH
first binds in the position competent for hydride donation to
the flavinN5 atom.Next, NADP slides over the flavin to adopt
the conformation observed in the NADP-bound crystal
structures. The elucidated PAMO-NADP structure fully con-
forms to this proposal (Scheme 1).
A fundamental question for the functioning of BVMOs and,
more generally, for flavin and oxygen enzymology, is to under-
stand the nature of the essential role played by NADP in fla-
vin-peroxide stabilization (Scheme 1). This flavin intermediate
is characterized by an absorption peak in the 360–390-nm
region, oftenwith an extinction coefficient similar to that of the
	370-nm peak of the fully oxidized flavin (3, 9). As shown in
Fig. 3, spectra measured during reoxidation (see spectrum C)
are nearly identical to the spectrum of the oxidized enzyme
from 360 nm to 390 nm, whereas their absorbance in
the 450-nm region is well below that of the oxidized flavin.
These findings suggest that a fraction (	20%) of the crystalline
enzyme molecules might be in the flavin-peroxide form during
reoxidation. However, crystal spectra never indicated substan-
tial (
50% occupancy) accumulation of the intermediate in the
crystals. Apparently, the crystalline environment and highly
viscous crystallization solutions prevent intermediate accumu-
lation, possibly because the rate of its formation in the crystals is
slower than that of its decay. Furthermore, the putative low
occupancy flavin-peroxide intermediate seen in the spectrum is
immediately reduced by x-rays. Nevertheless, the structure of
reduced PAMO with NADP provides considerable insight
into flavin-peroxide formation. A key observation is that the
carboxamide group of NADP establishes an H-bond with the
N5 atom of the reduced flavin (Fig. 2B). Such an H-bond pro-
tects the reduced flavin from losing its N5 proton to the sur-
rounding medium, and its has been recently highlighted by
studies on various enzymes that stabilize the flavin-(hydro)per-
oxide, including flavin-containing monooxygenases (7), p-
hydroxyphenylacetate hydroxylase, and pyranose oxidase (37,
38). Transient proton exchange (with solvent or neighboring
groups) is thought to favor the decay of the intermediate, whose
stability requires a stably protonatedN5 atom (8). In particular,
FIGURE 3.Microspectrophotometry of PAMOcrystalsmeasured at 100 K.
Soaking the crystals at room temperature prior to cryo-cooling in dithionite-
containing solutions leads to the reduction of the crystalline enzyme (spec-
trum A, bold line). Reduced crystals can be reoxidized by soaking at room
temperature in aerated solutions as shown by spectra B, C, andD, whichwere
collected on crystals that were cryo-cooled 2, 4, and 6min after beginning of
reoxidation. Spectrum D corresponds to that of the fully reoxidized enzyme,
which is indistinguishable from that measured on oxidized crystals directly
harvested from the crystallization droplets. The inset shows the flavin reduc-
tion during routine x-ray diffraction data collection at 100 K measured at
different x-ray exposure times. The flavin is completely reduced, typically
after 5–30 s of irradiation.
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an “unprotected” N5 could donate the proton directly to the
distal oxygen of the flavin-peroxide adduct, inevitably leading
to intermediate collapse. Thus, the emerging fundamental con-
cept is that NADP is required for oxygen-activation primarily
by providing essential H-bonding interactions that modulate
flavin reactivity.
Another insightful observation from the structure of the
reduced enzyme-NADP complex concerns Arg-337, which
adopts an extended conformation to interact with the nega-
tively charged reduced flavin (Fig. 2B). This conformation
obstructs the site for the organic substrate, whose catalytically
competent binding is prevented prior to the reaction with
dioxygen to maintain the C4a-N5 locus of the reduced flavin
readily accessible for dioxygen. Upon formation of the flavin-
peroxide and the concomitant loss of the negative charge on the
flavin ring, Arg-337 shifts back to the conformation interacting
with the NADP nicotinamide, making the catalytic center
accessible to the substrate (Figs. 2,A and B, and 4,A andC, and
Scheme 1). This observation is consistent with multisubstrate
kinetic studies. The order ofNADPHand substrate bindingwas
studied for the R217A mutant of PAMO, which features a Km
for NADPH (320 M) suited for this type of experiments (the
mutation is unlikely to affect the reaction mechanism because
Arg-217 is located far away from the flavin) (39). When the
observed reaction rates were plotted according to Lineweaver-
Burk method, the characteristic pattern of parallel lines was
observed, indicating an ordered binding of substrates. In par-
ticular, the parallel lines are consistent with a sequential mech-
anism with an intervening irreversible step (i.e. flavin reoxida-
tion). The binding location of MES in the D66A structure
further suggests that the extended conformation of Arg-337
might represent a steering element for the substrate, guiding it
into the active site upon flavin-peroxide formation (Scheme 1).
The structure of the enzyme in complex with MES indicates
that Arg-337 and the NADP ribose cooperate in forming a
binding site for a negative charge. We modeled the Criegee
intermediate using the complex with MES as reference struc-
ture (Fig. 4D). The model was built by positioning the interme-
diate tetrahedral group on the site occupied by the sulfonic
moiety of MES and by positioning the phenylacetone ring in a
location overlapping that of MES morpholino group. Such a
modeling experiment reveals that the Criegee intermediate can
be perfectly accommodated in the active site with Arg-337 and
NADP-ribose acting as the H-bond donors for the negatively
FIGURE 4.MES binding to PAMO. A, in the wild-type protein, binding involves H-bondingwith Arg-337, which further interacts with Asp-66. B, in R337K, MES
binds in a similar position but is unable to directly H-bond to Lys-337. C, structure of D66Amutant shows aMESmolecule in the funnel that leads to the active
site. Arg-337 of the oxidizedwild-type enzyme is superimposed and shown in thin lines.D, model of Criegee intermediate (see also Scheme 1) in BVMOs. Colors
are as in Fig. 2A.
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charge oxygen of the tetrahedral group. At the same time, the
sulfur atom of the MES sulfonic group mimics the carbonyl
carbon of the substrate that is covalently attacked by the termi-
nal oxygen of the flavin-peroxide (Fig. 4D). In this scenario,
Arg-337 has a dual role in substrate oxygenation: (i) it H-bonds
to the carbonyl oxygen of the substrate enhancing the propen-
sity of the carbonyl carbon to undergo the nucleophilic attack
by the flavin-peroxide, and (ii) together with the NADP
ribose, it compensates for the negative charge of the Criegee
intermediate.
It is worth noting that the active-site architecture does not
identify clear elements for recognition of specific substrate(s).
Rather, the active site appears to be primarily designed to acti-
vate dioxygen through flavin-peroxide stabilization and to sta-
bilize the Criegee intermediate. In other words, PAMO and
similar BVMOs aremainly oxygen-activating and “Criegee-sta-
bilizing” catalysts that act on any chemically suitable substrate
that can diffuse into the active site and reach the catalytic center
where the flavin-peroxide and oxyanion hole are positioned.
Along these lines, it is not surprising that substrate specificity of
PAMO and similar enzymes can be manipulated by simple
mutations such as those targetingMet-446. These data empha-
size the potential of using PAMO and similar BVMOs as tool-
boxes for biocatalytic applications and support the idea that
protein engineering and directed evolution methods can be
used effectively to develop finely tuned biocatalysts.
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Supplementary Figure 1. Ramachandran plot for Arg337Lys protein in complex with MES 
(which has the lowest resolution structure in our study; Table 1). The plot exemplifies the quality of 
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